NGO advocates solution for sickle cell anaemia, thalassemia
A Non-Government Organisation, Word Health Care Foundation has advocated In-vivo gene therapy for the permanent treatment of Sickle Cell disease, Thalassemia and Hemoglobinopathy.
The foundation said, the HS 1.0 (Proprietary name) is a 14-day innovative treatment that precisely acts to stimulate the body in producing Foetal Red Blood Cells in a process known as “Hematopoiesis.”
READ ALSO: Sickle cell: Pfizer, foundation raises awareness to reduce prevalence
“It (HS 1.0) simultaneously reverses the mutation in the hemoglobin genes which produce the sickle cells in the blood.
“This innovative therapeutic formula produces adequate threshold of normal Red Blood Cells after four days of continuous treatment, enough to forestall any Vaso Occlusive Crisis (VOC) or inflammatory responses arising therefrom while the treatment continues to the fourteenth day. We, however, generously extend this to fifteen days to compensate for full compliance.”
Prior to starting the treatment, a Hemoglobin Electrophoresis Test of the patient’s blood is conducted to set a baseline which will be measured after six months of treatment in a post-treatment HB Electrophoresis Test.
According to the foundation, the reason for six months period post-treatment Test is that under the current genotype screening protocol, medical laboratory science can only detect the density in new blood (Hb F) after six months, hence called Adult Hemoglobin (Hb A).
The cure, is however said to have been achieved by World Health Organisation (WHO), when other underlying conditions associated with this disorder have been exhaustively treated.
On the dosage, is 300 ml (30 cl) of liquid formula taken 3 times daily for ages 6 months to 11 years while people from 11 and above can take 300 ml (30 cl).
“The formulation is entirely of non-synthetic chemicals rather, Phyto Stem Cell aggregates with organic precursors and additives. It is classified as BIOLOGICS.
“This makes HS 1.0 a very safe BIOLOGICS with no side effects. It is like a Therapeutic Supplement.
“Hemostim mode of action is not selective but works fully on all patients,” the foundation added.
